Last reviewed · How we verify
Org 36286 — Competitive Intelligence Brief
marketed
Follicle-stimulating hormone receptor
Other
Recombinant protein
Live · refreshed every 30 min
Target snapshot
Org 36286 (CORIFOLLITROPIN ALFA) — Merck Sharp & Dohme Limited.
Comparator set (3 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Org 36286 TARGET | CORIFOLLITROPIN ALFA | Merck Sharp & Dohme Limited | marketed | Follicle-stimulating hormone receptor | 2010-01-01 | |
| Urofollitropin | FOLLITROPIN | Serono | marketed | Gonadotropin [EPC] | Follicle-stimulating hormone receptor | 1986-01-01 |
| Metformin and FSHr | Metformin and FSHr | Assistance Publique - Hôpitaux de Paris | marketed | Combination therapy: biguanide + gonadotropin receptor agonist | Metformin: mitochondrial glycerophosphate dehydrogenase; FSHr: follicle-stimulating hormone receptor | |
| Elonva | Elonva | University Medical Centre Ljubljana | marketed | Follicle-stimulating hormone receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
Cite this brief
Drug Landscape (2026). Org 36286 — Competitive Intelligence Brief. https://druglandscape.com/ci/corifollitropin-alfa. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab